intrinsic therapeutics
-
Regulatory
Surgeons Taking New Steps to Build on Barricaid Facility Coding Success, Specialty Society Guidelines
Woburn, MA, June 1, 2020 – Physician enthusiasm is growing for Intrinsic’s Barricaid technology for managing lumbar disc herniation. While…
Read More » -
Spine
NYU Langone Performs First U.S. Procedure with Newly Approved Device to Reduce Herniated Disc Recurrence
NEW YORK, June 12, 2019 /PRNewswire/ — NYU Langone Health last month became the first center in the United States to perform a discectomy…
Read More » -
Financial
Intrinsic Therapeutics Completes $52m Financing to Fuel Commercial Efforts in the United States to Benefit Lumbar Discectomy Patients
BOSTON, April 11, 2019 /PRNewswire/ — Intrinsic Therapeutics, Inc., a medical device company focusing on surgeries to treat leg and low back pain…
Read More » -
Spine
Pivotal Clinical Trial Demonstrates Superiority of Anular Closure Compared to Standard Lumbar Discectomy
BOSTON, May 23, 2018 /PRNewswire/ — Intrinsic Therapeutics, Inc., a medical device company focusing on spinal disc therapies, today announced the publication of…
Read More » -
Hospitals
FDA Panel Gives Thumbs Down to Spine Device
By Joyce Frieden, News Editor, MedPage Today/December 13, 2017 GAITHERSBURG, Md. — An FDA advisory committee voted 5-8 Tuesday, with one abstention,…
Read More » -
Financial
Intrinsic Therapeutics raises $17.2M for spinal surgery devices
[gview file=”https://orthospinenews.com/wp-content/uploads/2014/09/SEC-Intrinsic-Therapeutics.pdf”]
Read More »